Oncogen

Novugen Oncology, formerly known as OncoGen Pharma, is a fully integrated pharmaceutical company based in Malaysia that specializes in the development and manufacturing of high-barrier oncology products. The company operates advanced research and development facilities for both active pharmaceutical ingredients (API) and finished dosage forms (FDF), positioning itself as a key vertically integrated player in the ASEAN region. Novugen focuses on providing affordable access to complex generic and innovative cancer treatments, having secured USFDA approvals for products such as abiraterone. Through strategic partnerships and a global outlook, the company aims to minimize import costs for niche medications while expanding its footprint into regulated markets like the United States.